data_6dzb_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6dzb _Structure_validation_residue.Date_analyzed 2019-05-10 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.29 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -39.61 159.06 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.469 -0.365 . . . . 0.0 110.672 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.47 53.45 1.97 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.548 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 141.86 132.9 2.8 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.524 ' N ' ' O ' ' A' ' 12' ' ' ILE . 57.9 m-85 -129.02 139.34 52.11 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.726 0.298 . . . . 0.0 110.38 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -71.41 91.67 1.03 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.033 0.444 . . . . 0.0 110.465 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -119.35 89.62 3.17 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.93 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . 0.511 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -78.89 22.96 0.64 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.008 1.805 . . . . 0.0 111.46 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.511 ' H ' ' C ' ' A' ' 8' ' ' DPR . 4.1 mtmm -138.26 153.68 49.07 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.3 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 mm -117.97 125.63 74.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.134 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -137.11 159.27 36.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.071 -179.614 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 0.1 OUTLIER -90.58 142.64 27.54 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.435 179.747 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 15' ' ' GLU . 18.8 t-20 -137.39 -98.39 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.833 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.528 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 1.4 tt0 -52.93 133.4 37.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.664 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' A' ' 15' ' ' GLU . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.401 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.502 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.641 ' HG ' ' H ' ' A' ' 3' ' ' ARG . 38.9 t -135.32 -140.27 0.17 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.888 0.375 . . . . 0.0 110.511 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.641 ' H ' ' HG ' ' A' ' 2' ' ' SER . 20.8 ttt180 -138.3 164.02 30.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.543 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.407 ' N ' ' CG ' ' A' ' 3' ' ' ARG . . . -42.63 161.31 0.04 OUTLIER Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -115.52 142.65 46.44 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.83 0.347 . . . . 0.0 110.562 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.6 ttm-85 -77.65 90.59 3.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.524 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -115.45 89.17 3.04 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.031 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . 0.517 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -77.13 18.37 0.78 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.79 1.66 . . . . 0.0 111.524 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.517 ' H ' ' C ' ' A' ' 8' ' ' DPR . 25.8 mmtm -131.31 152.75 50.27 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.74 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 mm -117.92 124.36 72.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.902 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -137.04 156.07 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.06 0.457 . . . . 0.0 111.144 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.41 ' CD2' ' C ' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -89.78 154.21 20.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.608 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -121.15 -69.38 0.84 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.341 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -124.07 114.81 20.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.473 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.576 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.55 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.695 ' HG ' ' H ' ' A' ' 3' ' ' ARG . 30.4 t -138.29 -151.86 0.4 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.079 0.466 . . . . 0.0 110.855 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.695 ' H ' ' HG ' ' A' ' 2' ' ' SER . 5.2 ptt180 -75.99 170.93 15.33 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.879 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.67 -169.71 26.54 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -121.74 134.64 54.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.779 0.323 . . . . 0.0 110.548 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.6 ttp180 -87.78 88.88 7.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.492 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -115.8 88.36 2.87 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.268 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . 0.526 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -77.27 20.13 0.68 Allowed 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.827 1.684 . . . . 0.0 111.548 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.526 ' H ' ' C ' ' A' ' 8' ' ' DPR . 25.4 mmtp -127.89 139.52 52.56 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.466 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 mm -115.73 133.72 61.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.285 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -115.09 161.13 14.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.308 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -97.65 -29.8 13.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.676 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.472 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 17.1 t30 40.05 -99.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.593 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.472 ' N ' ' CG ' ' A' ' 14' ' ' ASN . 7.3 tp10 -66.06 68.62 0.05 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.441 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 14' ' ' ASN . 9.8 tpp180 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.717 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.509 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.601 ' HG ' ' H ' ' A' ' 3' ' ' ARG . 36.6 t -135.92 -140.62 0.17 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.848 0.356 . . . . 0.0 110.723 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.601 ' H ' ' HG ' ' A' ' 2' ' ' SER . 10.1 ttm-85 -133.34 162.9 30.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.473 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.437 ' N ' ' CG ' ' A' ' 3' ' ' ARG . . . -44.67 170.39 0.01 OUTLIER Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -123.92 137.02 54.69 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.888 0.375 . . . . 0.0 110.663 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -73.42 91.62 1.78 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.371 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -115.71 88.78 2.96 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.1 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . 0.501 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -80.05 24.57 0.63 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.095 1.863 . . . . 0.0 111.404 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.501 ' H ' ' C ' ' A' ' 8' ' ' DPR . 4.7 mtpp -141.58 148.09 38.73 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.464 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 mm -112.76 126.65 70.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.919 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -137.38 155.23 31.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.071 0.462 . . . . 0.0 111.064 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.432 ' CD2' ' C ' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -87.9 156.15 19.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.56 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.46 -69.08 0.78 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.461 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.16 107.34 12.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.474 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.474 179.982 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.555 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.461 ' OG ' ' N ' ' A' ' 3' ' ' ARG . 47.4 t -104.86 -137.84 0.36 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.651 0.262 . . . . 0.0 110.575 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.513 ' O ' ' CZ ' ' A' ' 5' ' ' PHE . 5.3 ttt-85 -124.82 150.35 46.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.461 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.55 161.88 34.16 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.513 ' CZ ' ' O ' ' A' ' 3' ' ' ARG . 1.4 m-85 -137.97 155.29 49.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.778 0.323 . . . . 0.0 110.698 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -67.56 97.01 0.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.71 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -115.0 89.67 3.15 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.803 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . 0.538 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -78.57 23.61 0.6 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.873 1.716 . . . . 0.0 111.349 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.538 ' H ' ' C ' ' A' ' 8' ' ' DPR . 10.3 mttm -142.97 165.52 27.14 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.262 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 mm -119.93 121.62 66.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.029 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.2 mt -141.06 160.13 23.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.014 0.435 . . . . 0.0 111.021 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.81 176.35 5.1 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.673 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -96.69 -38.87 9.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.564 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -140.48 117.34 11.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.624 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 10.4 tpp180 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.593 -179.965 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.516 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.617 ' CB ' ' H ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -62.98 152.22 37.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.847 0.356 . . . . 0.0 110.733 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.4 tpt85 -93.35 5.65 50.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.594 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.3 162.03 27.34 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.432 ' N ' ' O ' ' A' ' 12' ' ' ILE . 39.3 m-85 -138.03 131.64 30.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.836 0.35 . . . . 0.0 110.542 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -77.26 95.86 4.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.353 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -123.18 88.37 2.91 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.201 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . 0.531 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -76.78 19.88 0.64 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.894 1.729 . . . . 0.0 111.545 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.531 ' H ' ' C ' ' A' ' 8' ' ' DPR . 20.0 tptt -130.22 159.39 37.01 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.055 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 mm -128.37 130.24 69.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.244 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.432 ' O ' ' N ' ' A' ' 5' ' ' PHE . 0.6 OUTLIER -137.08 156.18 33.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.991 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.71 166.74 10.32 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.334 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.617 ' H ' ' CB ' ' A' ' 2' ' ' SER . 0.9 OUTLIER -71.1 -105.16 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.45 179.821 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -103.91 -63.02 1.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.142 0.496 . . . . 0.0 110.599 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.32 -0.715 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.638 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.562 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.588 ' HG ' ' H ' ' A' ' 3' ' ' ARG . 31.6 t -103.74 -149.42 0.4 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.832 0.348 . . . . 0.0 110.726 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.665 ' CG ' ' H ' ' A' ' 4' ' ' GLY . 3.6 tpt180 -134.39 -143.81 0.21 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.151 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.665 ' H ' ' CG ' ' A' ' 3' ' ' ARG . . . -40.27 156.56 0.03 OUTLIER Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.515 ' N ' ' O ' ' A' ' 12' ' ' ILE . 37.5 m-85 -132.59 135.54 45.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.817 0.341 . . . . 0.0 110.398 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -75.89 92.66 3.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.419 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.76 87.79 2.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.036 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . 0.515 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -79.47 24.09 0.63 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.968 1.778 . . . . 0.0 111.419 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.515 ' H ' ' C ' ' A' ' 8' ' ' DPR . 11.1 mttp -137.53 146.07 43.69 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.128 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 mm -114.71 129.16 71.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.296 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.515 ' O ' ' N ' ' A' ' 5' ' ' PHE . 0.3 OUTLIER -137.91 154.85 29.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.915 0.388 . . . . 0.0 110.854 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.77 142.61 30.09 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.585 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 15' ' ' GLU . 11.0 t-20 -109.73 -131.91 0.32 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.478 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.517 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 3.1 tt0 -154.07 28.18 0.46 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.533 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.8 ttt180 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.506 -179.979 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.63 0 N-CA-C 111.234 -0.747 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.522 ' OG ' ' N ' ' A' ' 3' ' ' ARG . 1.1 t -91.92 177.69 6.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.905 0.383 . . . . 0.0 110.616 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.522 ' N ' ' OG ' ' A' ' 2' ' ' SER . 0.0 OUTLIER -93.22 20.35 7.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.496 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 52.46 -177.77 0.1 Allowed Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -135.03 136.34 42.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.771 0.32 . . . . 0.0 110.596 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 13.7 ttp180 -85.12 94.47 8.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.471 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.25 86.28 2.46 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.164 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . 0.523 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -77.79 21.62 0.64 Allowed 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.874 1.716 . . . . 0.0 111.506 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.523 ' H ' ' C ' ' A' ' 8' ' ' DPR . 10.7 mtmm -131.81 140.06 49.06 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.052 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.53 138.9 45.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.341 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -114.66 159.72 14.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.357 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -112.48 -22.44 10.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.646 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.466 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 12.4 t30 49.31 -96.94 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.468 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.466 ' N ' ' CG ' ' A' ' 14' ' ' ASN . 28.2 tp10 -99.2 108.11 20.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.419 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.739 -179.975 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.65 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.703 ' HG ' ' H ' ' A' ' 3' ' ' ARG . 40.0 t -69.39 -139.83 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.88 0.371 . . . . 0.0 110.61 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.703 ' H ' ' HG ' ' A' ' 2' ' ' SER . 38.3 ttp85 -45.41 148.46 0.66 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.483 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -141.45 177.92 20.79 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -132.69 137.92 47.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.734 0.302 . . . . 0.0 110.417 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -84.01 95.52 8.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.461 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -115.86 87.96 2.78 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.294 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . 0.535 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -77.22 20.19 0.67 Allowed 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 121.748 1.632 . . . . 0.0 111.391 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.535 ' H ' ' C ' ' A' ' 8' ' ' DPR . 0.2 OUTLIER -127.94 158.16 38.59 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.061 179.795 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 mm -132.88 138.64 51.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.435 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.41 159.46 11.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.149 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -103.53 -177.45 3.37 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.725 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.593 HD22 ' NH2' ' A' ' 3' ' ' ARG . 0.3 OUTLIER -102.84 -60.01 1.62 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.339 179.673 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -152.73 -14.51 0.16 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.503 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.517 ' C ' ' H ' ' A' ' 2' ' ' SER . 49.4 ttt180 . . . . . 0 C--N 1.325 -0.491 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.849 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 CA--C 1.524 0.614 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.531 ' OG ' ' N ' ' A' ' 3' ' ' ARG . 1.4 t 49.53 177.72 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.961 0.41 . . . . 0.0 110.863 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.531 ' N ' ' OG ' ' A' ' 2' ' ' SER . 1.8 tpm_? -100.83 148.48 24.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.666 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.86 167.62 0.47 Allowed Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -133.59 126.49 31.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.822 0.344 . . . . 0.0 110.62 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.8 ptt85 -66.57 93.5 0.24 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.927 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -116.19 86.85 2.56 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.993 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . 0.549 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -76.16 18.05 0.69 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 121.715 1.61 . . . . 0.0 111.415 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.549 ' H ' ' C ' ' A' ' 8' ' ' DPR . 2.8 mmmm -130.48 141.84 50.5 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.17 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 mm -110.69 124.06 67.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.169 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -136.52 155.94 34.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.101 0.477 . . . . 0.0 111.109 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.65 171.94 7.13 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.303 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.445 ' C ' ' ND2' ' A' ' 14' ' ' ASN . 0.8 OUTLIER -58.01 -99.89 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.314 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -163.82 4.56 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.522 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.7 ttm180 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.725 -179.881 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.29 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -39.61 159.06 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.469 -0.365 . . . . 0.0 110.672 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.47 53.45 1.97 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.548 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 141.86 132.9 2.8 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.524 ' N ' ' O ' ' A' ' 12' ' ' ILE . 57.9 m-85 -129.02 139.34 52.11 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.726 0.298 . . . . 0.0 110.38 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -71.41 91.67 1.03 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.033 0.444 . . . . 0.0 110.465 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -119.35 89.62 3.17 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.93 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' DPR . . . . . 0.477 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -78.89 22.96 0.64 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.008 1.805 . . . . 0.0 111.46 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.477 ' H ' ' C ' ' A' ' 8' ' ' DPR . 4.1 mtmm -138.26 153.68 49.07 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.3 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 mm -117.97 125.63 74.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.134 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -137.11 159.27 36.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.071 -179.614 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 0.1 OUTLIER -90.58 142.64 27.54 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.435 179.747 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 15' ' ' GLU . 18.8 t-20 -137.39 -98.39 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.833 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.528 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 1.4 tt0 -52.93 133.4 37.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.664 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' A' ' 15' ' ' GLU . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.401 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.502 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.441 ' OG ' ' N ' ' A' ' 3' ' ' ARG . 38.9 t -135.32 -140.27 0.17 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.888 0.375 . . . . 0.0 110.511 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.441 ' N ' ' OG ' ' A' ' 2' ' ' SER . 20.8 ttt180 -138.3 164.02 30.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.543 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.407 ' N ' ' CG ' ' A' ' 3' ' ' ARG . . . -42.63 161.31 0.04 OUTLIER Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -115.52 142.65 46.44 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.83 0.347 . . . . 0.0 110.562 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.6 ttm-85 -77.65 90.59 3.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.524 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -115.45 89.17 3.04 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.031 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' DPR . . . . . 0.488 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -77.13 18.37 0.78 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.79 1.66 . . . . 0.0 111.524 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.488 ' H ' ' C ' ' A' ' 8' ' ' DPR . 25.8 mmtm -131.31 152.75 50.27 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.74 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 mm -117.92 124.36 72.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.902 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -137.04 156.07 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.06 0.457 . . . . 0.0 111.144 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.41 ' CD2' ' C ' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -89.78 154.21 20.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.608 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -121.15 -69.38 0.84 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.341 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -124.07 114.81 20.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.473 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.576 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.55 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.434 ' OG ' ' N ' ' A' ' 3' ' ' ARG . 30.4 t -138.29 -151.86 0.4 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.079 0.466 . . . . 0.0 110.855 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.434 ' N ' ' OG ' ' A' ' 2' ' ' SER . 5.2 ptt180 -75.99 170.93 15.33 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.879 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.67 -169.71 26.54 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -121.74 134.64 54.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.779 0.323 . . . . 0.0 110.548 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.6 ttp180 -87.78 88.88 7.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.492 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -115.8 88.36 2.87 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.268 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' DPR . . . . . 0.488 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -77.27 20.13 0.68 Allowed 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.827 1.684 . . . . 0.0 111.548 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.488 ' H ' ' C ' ' A' ' 8' ' ' DPR . 25.4 mmtp -127.89 139.52 52.56 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.466 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 mm -115.73 133.72 61.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.285 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -115.09 161.13 14.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.308 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -97.65 -29.8 13.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.676 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.472 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 17.1 t30 40.05 -99.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.593 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.472 ' N ' ' CG ' ' A' ' 14' ' ' ASN . 7.3 tp10 -66.06 68.62 0.05 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.441 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 14' ' ' ASN . 9.8 tpp180 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.717 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.509 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.419 ' OG ' ' N ' ' A' ' 3' ' ' ARG . 36.6 t -135.92 -140.62 0.17 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.848 0.356 . . . . 0.0 110.723 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.437 ' CG ' ' N ' ' A' ' 4' ' ' GLY . 10.1 ttm-85 -133.34 162.9 30.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.473 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.437 ' N ' ' CG ' ' A' ' 3' ' ' ARG . . . -44.67 170.39 0.01 OUTLIER Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -123.92 137.02 54.69 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.888 0.375 . . . . 0.0 110.663 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -73.42 91.62 1.78 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.371 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -115.71 88.78 2.96 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.1 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' DPR . . . . . 0.461 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -80.05 24.57 0.63 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.095 1.863 . . . . 0.0 111.404 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.461 ' H ' ' C ' ' A' ' 8' ' ' DPR . 4.7 mtpp -141.58 148.09 38.73 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.464 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 mm -112.76 126.65 70.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.919 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -137.38 155.23 31.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.071 0.462 . . . . 0.0 111.064 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.432 ' CD2' ' C ' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -87.9 156.15 19.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.56 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -126.46 -69.08 0.78 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.461 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.16 107.34 12.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.474 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.474 179.982 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.555 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.461 ' OG ' ' N ' ' A' ' 3' ' ' ARG . 47.4 t -104.86 -137.84 0.36 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.651 0.262 . . . . 0.0 110.575 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.513 ' O ' ' CZ ' ' A' ' 5' ' ' PHE . 5.3 ttt-85 -124.82 150.35 46.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.461 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.55 161.88 34.16 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.513 ' CZ ' ' O ' ' A' ' 3' ' ' ARG . 1.4 m-85 -137.97 155.29 49.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.778 0.323 . . . . 0.0 110.698 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -67.56 97.01 0.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.71 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -115.0 89.67 3.15 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.803 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' DPR . . . . . 0.495 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -78.57 23.61 0.6 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.873 1.716 . . . . 0.0 111.349 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.495 ' H ' ' C ' ' A' ' 8' ' ' DPR . 10.3 mttm -142.97 165.52 27.14 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.262 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 mm -119.93 121.62 66.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.029 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.2 mt -141.06 160.13 23.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.014 0.435 . . . . 0.0 111.021 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.81 176.35 5.1 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.673 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -96.69 -38.87 9.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.564 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -140.48 117.34 11.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.624 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 10.4 tpp180 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.593 -179.965 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.516 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.653 ' CB ' ' H ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -62.98 152.22 37.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.847 0.356 . . . . 0.0 110.733 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.4 tpt85 -93.35 5.65 50.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.594 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.3 162.03 27.34 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.432 ' N ' ' O ' ' A' ' 12' ' ' ILE . 39.3 m-85 -138.03 131.64 30.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.836 0.35 . . . . 0.0 110.542 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -77.26 95.86 4.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.353 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -123.18 88.37 2.91 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.201 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' DPR . . . . . 0.486 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -76.78 19.88 0.64 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.894 1.729 . . . . 0.0 111.545 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.486 ' H ' ' C ' ' A' ' 8' ' ' DPR . 20.0 tptt -130.22 159.39 37.01 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.055 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 mm -128.37 130.24 69.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.244 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.432 ' O ' ' N ' ' A' ' 5' ' ' PHE . 0.6 OUTLIER -137.08 156.18 33.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.991 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.71 166.74 10.32 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.334 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.653 ' H ' ' CB ' ' A' ' 2' ' ' SER . 40.1 t30 -71.1 -105.16 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.45 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -103.91 -63.02 1.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.142 0.496 . . . . 0.0 110.599 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.32 -0.715 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.638 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.562 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.434 ' OG ' ' N ' ' A' ' 3' ' ' ARG . 31.6 t -103.74 -149.42 0.4 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.832 0.348 . . . . 0.0 110.726 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.642 ' CG ' ' H ' ' A' ' 4' ' ' GLY . 3.6 tpt180 -134.39 -143.81 0.21 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.151 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.642 ' H ' ' CG ' ' A' ' 3' ' ' ARG . . . -40.27 156.56 0.03 OUTLIER Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.515 ' N ' ' O ' ' A' ' 12' ' ' ILE . 37.5 m-85 -132.59 135.54 45.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.817 0.341 . . . . 0.0 110.398 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -75.89 92.66 3.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.419 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.76 87.79 2.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.036 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' DPR . . . . . 0.473 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -79.47 24.09 0.63 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.968 1.778 . . . . 0.0 111.419 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.473 ' H ' ' C ' ' A' ' 8' ' ' DPR . 11.1 mttp -137.53 146.07 43.69 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.128 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 mm -114.71 129.16 71.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.296 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.515 ' O ' ' N ' ' A' ' 5' ' ' PHE . 0.3 OUTLIER -137.91 154.85 29.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.915 0.388 . . . . 0.0 110.854 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.77 142.61 30.09 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.585 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 15' ' ' GLU . 11.0 t-20 -109.73 -131.91 0.32 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.478 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.517 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 3.1 tt0 -154.07 28.18 0.46 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.533 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.8 ttt180 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.506 -179.979 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.63 0 N-CA-C 111.234 -0.747 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.522 ' OG ' ' N ' ' A' ' 3' ' ' ARG . 1.1 t -91.92 177.69 6.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.905 0.383 . . . . 0.0 110.616 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.522 ' N ' ' OG ' ' A' ' 2' ' ' SER . 0.0 OUTLIER -93.22 20.35 7.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.496 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 52.46 -177.77 0.1 Allowed Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -135.03 136.34 42.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.771 0.32 . . . . 0.0 110.596 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 13.7 ttp180 -85.12 94.47 8.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.471 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.25 86.28 2.46 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.164 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' DPR . . . . . 0.484 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -77.79 21.62 0.64 Allowed 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.874 1.716 . . . . 0.0 111.506 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.484 ' H ' ' C ' ' A' ' 8' ' ' DPR . 10.7 mtmm -131.81 140.06 49.06 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.052 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.53 138.9 45.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.341 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -114.66 159.72 14.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.357 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -112.48 -22.44 10.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.646 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.466 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 12.4 t30 49.31 -96.94 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.468 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.466 ' N ' ' CG ' ' A' ' 14' ' ' ASN . 28.2 tp10 -99.2 108.11 20.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.419 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.739 -179.975 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.65 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.482 ' H ' ' C ' ' A' ' 16' ' ' ARG . 40.0 t -69.39 -139.83 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.88 0.371 . . . . 0.0 110.61 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.63 ' NH2' HD21 ' A' ' 14' ' ' ASN . 38.3 ttp85 -45.41 148.46 0.66 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.483 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -141.45 177.92 20.79 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -132.69 137.92 47.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.734 0.302 . . . . 0.0 110.417 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -84.01 95.52 8.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.461 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -115.86 87.96 2.78 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.294 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' DPR . . . . . 0.501 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -77.22 20.19 0.67 Allowed 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 121.748 1.632 . . . . 0.0 111.391 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.501 ' H ' ' C ' ' A' ' 8' ' ' DPR . 0.2 OUTLIER -127.94 158.16 38.59 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.061 179.795 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 mm -132.88 138.64 51.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.435 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.41 159.46 11.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.149 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -103.53 -177.45 3.37 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.725 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.63 HD21 ' NH2' ' A' ' 3' ' ' ARG . 0.3 OUTLIER -102.84 -60.01 1.62 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.339 179.673 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -152.73 -14.51 0.16 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.503 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.482 ' C ' ' H ' ' A' ' 2' ' ' SER . 49.4 ttt180 . . . . . 0 C--N 1.325 -0.491 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.849 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 CA--C 1.524 0.614 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.531 ' OG ' ' N ' ' A' ' 3' ' ' ARG . 1.4 t 49.53 177.72 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.961 0.41 . . . . 0.0 110.863 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.531 ' N ' ' OG ' ' A' ' 2' ' ' SER . 1.8 tpm_? -100.83 148.48 24.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.666 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.86 167.62 0.47 Allowed Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -133.59 126.49 31.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.822 0.344 . . . . 0.0 110.62 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.8 ptt85 -66.57 93.5 0.24 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.927 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -116.19 86.85 2.56 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.993 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' DPR . . . . . 0.498 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -76.16 18.05 0.69 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 121.715 1.61 . . . . 0.0 111.415 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.498 ' H ' ' C ' ' A' ' 8' ' ' DPR . 2.8 mmmm -130.48 141.84 50.5 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.17 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 mm -110.69 124.06 67.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.169 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -136.52 155.94 34.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.101 0.477 . . . . 0.0 111.109 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.65 171.94 7.13 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.303 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -58.01 -99.89 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.314 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -163.82 4.56 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.522 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.7 ttm180 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.725 -179.881 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.29 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -39.61 159.06 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.469 -0.365 . . . . 0.0 110.672 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.47 53.45 1.97 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.548 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 141.86 132.9 2.8 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.524 ' N ' ' O ' ' A' ' 12' ' ' ILE . 57.9 m-85 -129.02 139.34 52.11 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.726 0.298 . . . . 0.0 110.38 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -71.41 91.67 1.03 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.033 0.444 . . . . 0.0 110.465 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -119.35 89.62 3.17 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.93 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . 0.477 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -78.89 22.96 0.64 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.008 1.805 . . . . 0.0 111.46 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.477 ' H ' ' C ' ' A' ' 8' ' ' DPR . 4.1 mtmm -138.26 153.68 49.07 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.3 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 mm -117.97 125.63 74.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.134 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -137.11 159.27 36.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.071 -179.614 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 0.1 OUTLIER -90.58 142.64 27.54 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.435 179.747 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 15' ' ' GLU . 18.8 t-20 -137.39 -98.39 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.833 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.528 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 1.4 tt0 -52.93 133.4 37.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.664 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' A' ' 15' ' ' GLU . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.401 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.502 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.441 ' OG ' ' N ' ' A' ' 3' ' ' ARG . 38.9 t -135.32 -140.27 0.17 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.888 0.375 . . . . 0.0 110.511 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.441 ' N ' ' OG ' ' A' ' 2' ' ' SER . 20.8 ttt180 -138.3 164.02 30.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.543 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.407 ' N ' ' CG ' ' A' ' 3' ' ' ARG . . . -42.63 161.31 0.04 OUTLIER Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -115.52 142.65 46.44 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.83 0.347 . . . . 0.0 110.562 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.6 ttm-85 -77.65 90.59 3.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.524 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -115.45 89.17 3.04 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.031 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . 0.488 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -77.13 18.37 0.78 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.79 1.66 . . . . 0.0 111.524 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.488 ' H ' ' C ' ' A' ' 8' ' ' DPR . 25.8 mmtm -131.31 152.75 50.27 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.74 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 mm -117.92 124.36 72.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.902 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -137.04 156.07 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.06 0.457 . . . . 0.0 111.144 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.41 ' CD2' ' C ' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -89.78 154.21 20.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.608 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -121.15 -69.38 0.84 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.341 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -124.07 114.81 20.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.473 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.576 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.55 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.434 ' OG ' ' N ' ' A' ' 3' ' ' ARG . 30.4 t -138.29 -151.86 0.4 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.079 0.466 . . . . 0.0 110.855 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.434 ' N ' ' OG ' ' A' ' 2' ' ' SER . 5.2 ptt180 -75.99 170.93 15.33 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.879 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.67 -169.71 26.54 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -121.74 134.64 54.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.779 0.323 . . . . 0.0 110.548 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.6 ttp180 -87.78 88.88 7.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.492 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -115.8 88.36 2.87 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.268 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . 0.488 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -77.27 20.13 0.68 Allowed 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.827 1.684 . . . . 0.0 111.548 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.488 ' H ' ' C ' ' A' ' 8' ' ' DPR . 25.4 mmtp -127.89 139.52 52.56 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.466 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 mm -115.73 133.72 61.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.285 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -115.09 161.13 14.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.308 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -97.65 -29.8 13.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.676 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.472 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 17.1 t30 40.05 -99.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.593 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.472 ' N ' ' CG ' ' A' ' 14' ' ' ASN . 7.3 tp10 -66.06 68.62 0.05 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.441 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 14' ' ' ASN . 9.8 tpp180 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.717 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.509 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.419 ' OG ' ' N ' ' A' ' 3' ' ' ARG . 36.6 t -135.92 -140.62 0.17 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.848 0.356 . . . . 0.0 110.723 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.437 ' CG ' ' N ' ' A' ' 4' ' ' GLY . 10.1 ttm-85 -133.34 162.9 30.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.473 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.437 ' N ' ' CG ' ' A' ' 3' ' ' ARG . . . -44.67 170.39 0.01 OUTLIER Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -123.92 137.02 54.69 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.888 0.375 . . . . 0.0 110.663 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -73.42 91.62 1.78 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.371 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -115.71 88.78 2.96 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.1 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . 0.461 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -80.05 24.57 0.63 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.095 1.863 . . . . 0.0 111.404 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.461 ' H ' ' C ' ' A' ' 8' ' ' DPR . 4.7 mtpp -141.58 148.09 38.73 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.464 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 mm -112.76 126.65 70.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.919 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -137.38 155.23 31.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.071 0.462 . . . . 0.0 111.064 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.432 ' CD2' ' C ' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -87.9 156.15 19.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.56 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.46 -69.08 0.78 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.461 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.16 107.34 12.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.474 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.474 179.982 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.555 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.461 ' OG ' ' N ' ' A' ' 3' ' ' ARG . 47.4 t -104.86 -137.84 0.36 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.651 0.262 . . . . 0.0 110.575 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.513 ' O ' ' CZ ' ' A' ' 5' ' ' PHE . 5.3 ttt-85 -124.82 150.35 46.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.461 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.55 161.88 34.16 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.513 ' CZ ' ' O ' ' A' ' 3' ' ' ARG . 1.4 m-85 -137.97 155.29 49.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.778 0.323 . . . . 0.0 110.698 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -67.56 97.01 0.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.71 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -115.0 89.67 3.15 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.803 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . 0.495 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -78.57 23.61 0.6 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.873 1.716 . . . . 0.0 111.349 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.495 ' H ' ' C ' ' A' ' 8' ' ' DPR . 10.3 mttm -142.97 165.52 27.14 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.262 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 mm -119.93 121.62 66.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.029 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.2 mt -141.06 160.13 23.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.014 0.435 . . . . 0.0 111.021 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.81 176.35 5.1 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.673 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -96.69 -38.87 9.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.564 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -140.48 117.34 11.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.624 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 10.4 tpp180 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.593 -179.965 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.516 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.653 ' CB ' ' H ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -62.98 152.22 37.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.847 0.356 . . . . 0.0 110.733 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.4 tpt85 -93.35 5.65 50.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.594 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.3 162.03 27.34 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.432 ' N ' ' O ' ' A' ' 12' ' ' ILE . 39.3 m-85 -138.03 131.64 30.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.836 0.35 . . . . 0.0 110.542 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -77.26 95.86 4.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.353 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -123.18 88.37 2.91 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.201 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . 0.486 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -76.78 19.88 0.64 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.894 1.729 . . . . 0.0 111.545 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.486 ' H ' ' C ' ' A' ' 8' ' ' DPR . 20.0 tptt -130.22 159.39 37.01 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.055 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 mm -128.37 130.24 69.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.244 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.432 ' O ' ' N ' ' A' ' 5' ' ' PHE . 0.6 OUTLIER -137.08 156.18 33.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.991 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.71 166.74 10.32 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.334 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.653 ' H ' ' CB ' ' A' ' 2' ' ' SER . 0.9 OUTLIER -71.1 -105.16 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.45 179.821 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -103.91 -63.02 1.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.142 0.496 . . . . 0.0 110.599 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.32 -0.715 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.638 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.562 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.434 ' OG ' ' N ' ' A' ' 3' ' ' ARG . 31.6 t -103.74 -149.42 0.4 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.832 0.348 . . . . 0.0 110.726 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.642 ' CG ' ' H ' ' A' ' 4' ' ' GLY . 3.6 tpt180 -134.39 -143.81 0.21 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.151 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.642 ' H ' ' CG ' ' A' ' 3' ' ' ARG . . . -40.27 156.56 0.03 OUTLIER Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.515 ' N ' ' O ' ' A' ' 12' ' ' ILE . 37.5 m-85 -132.59 135.54 45.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.817 0.341 . . . . 0.0 110.398 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -75.89 92.66 3.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.419 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.76 87.79 2.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.036 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . 0.473 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -79.47 24.09 0.63 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.968 1.778 . . . . 0.0 111.419 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.473 ' H ' ' C ' ' A' ' 8' ' ' DPR . 11.1 mttp -137.53 146.07 43.69 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.128 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 mm -114.71 129.16 71.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.296 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.515 ' O ' ' N ' ' A' ' 5' ' ' PHE . 0.3 OUTLIER -137.91 154.85 29.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.915 0.388 . . . . 0.0 110.854 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.77 142.61 30.09 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.585 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 15' ' ' GLU . 11.0 t-20 -109.73 -131.91 0.32 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.478 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.517 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 3.1 tt0 -154.07 28.18 0.46 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.533 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.8 ttt180 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.506 -179.979 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.63 0 N-CA-C 111.234 -0.747 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.522 ' OG ' ' N ' ' A' ' 3' ' ' ARG . 1.1 t -91.92 177.69 6.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.905 0.383 . . . . 0.0 110.616 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.522 ' N ' ' OG ' ' A' ' 2' ' ' SER . 0.0 OUTLIER -93.22 20.35 7.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.496 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 52.46 -177.77 0.1 Allowed Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -135.03 136.34 42.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.771 0.32 . . . . 0.0 110.596 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 13.7 ttp180 -85.12 94.47 8.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.471 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.25 86.28 2.46 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.164 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . 0.484 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -77.79 21.62 0.64 Allowed 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.874 1.716 . . . . 0.0 111.506 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.484 ' H ' ' C ' ' A' ' 8' ' ' DPR . 10.7 mtmm -131.81 140.06 49.06 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.052 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.53 138.9 45.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.341 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -114.66 159.72 14.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.357 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -112.48 -22.44 10.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.646 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.466 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 12.4 t30 49.31 -96.94 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.468 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.466 ' N ' ' CG ' ' A' ' 14' ' ' ASN . 28.2 tp10 -99.2 108.11 20.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.419 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.739 -179.975 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.65 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.482 ' H ' ' C ' ' A' ' 16' ' ' ARG . 40.0 t -69.39 -139.83 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.88 0.371 . . . . 0.0 110.61 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.63 ' NH2' HD21 ' A' ' 14' ' ' ASN . 38.3 ttp85 -45.41 148.46 0.66 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.483 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -141.45 177.92 20.79 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -132.69 137.92 47.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.734 0.302 . . . . 0.0 110.417 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -84.01 95.52 8.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.461 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -115.86 87.96 2.78 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.294 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . 0.501 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -77.22 20.19 0.67 Allowed 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 121.748 1.632 . . . . 0.0 111.391 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.501 ' H ' ' C ' ' A' ' 8' ' ' DPR . 0.2 OUTLIER -127.94 158.16 38.59 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.061 179.795 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 mm -132.88 138.64 51.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.435 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.41 159.46 11.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.149 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -103.53 -177.45 3.37 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.725 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.63 HD21 ' NH2' ' A' ' 3' ' ' ARG . 0.3 OUTLIER -102.84 -60.01 1.62 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.339 179.673 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -152.73 -14.51 0.16 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.503 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.482 ' C ' ' H ' ' A' ' 2' ' ' SER . 49.4 ttt180 . . . . . 0 C--N 1.325 -0.491 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.849 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 CA--C 1.524 0.614 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.531 ' OG ' ' N ' ' A' ' 3' ' ' ARG . 1.4 t 49.53 177.72 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.961 0.41 . . . . 0.0 110.863 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.531 ' N ' ' OG ' ' A' ' 2' ' ' SER . 1.8 tpm_? -100.83 148.48 24.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.666 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.86 167.62 0.47 Allowed Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -133.59 126.49 31.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.822 0.344 . . . . 0.0 110.62 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.8 ptt85 -66.57 93.5 0.24 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.927 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -116.19 86.85 2.56 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.993 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . 0.498 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -76.16 18.05 0.69 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 121.715 1.61 . . . . 0.0 111.415 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.498 ' H ' ' C ' ' A' ' 8' ' ' DPR . 2.8 mmmm -130.48 141.84 50.5 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.17 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 mm -110.69 124.06 67.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.169 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -136.52 155.94 34.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.101 0.477 . . . . 0.0 111.109 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.65 171.94 7.13 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.303 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.445 ' C ' ' ND2' ' A' ' 14' ' ' ASN . 0.8 OUTLIER -58.01 -99.89 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.314 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -163.82 4.56 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.522 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.7 ttm180 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.725 -179.881 . . . . . . . . 0 0 . 1 stop_ save_